FDA fast track covers ART6043 plus olaparib in PARP inhibitor–naïve gBRCAm, HER2-negative locally advanced/metastatic breast ...

U.S. Fast Track designation of ART6043 underpinned by promising clinical data to date and high unmet need in gBRCA-mutated ...

A clinical-stage oncology company developing targeted therapies that exploit DNA damage response (DDR) vulnerabilities in ...

UK: A recent study finds that acute exercise suppresses colorectal cancer progression by altering the circulating proteome, accelerating DNA (deoxyribonucleic acid) repair, and boosting PNKP ...

Scientists and institutions present findings on evolution, genetics, and neuroscience, underscoring active research areas where mechanisms remain under investigation. Coverage includes the Cambrian ...

New educational videos raise awareness of Cockayne Syndrome and empower families and clinicians through trusted, ...

Within five years, the researchers believe blood tests for early diagnosis of Parkinson’s disease could begin to be tested in healthcare settings. Over the longer term, the findings may also support ...

As is often the case with cancer treatments, many patients are able to benefit from therapy for a time. Tumor activity ...

Researchers led by Brian Hoffman of Northwestern University and Michael Daly of the Uniformed Services University have ...

PDRN 'salmon DNA' skincare is trending on TikTok, and dermatologists say it could help improve skin barrier strength and hydration when used correctly ...

Running extreme distances may strain more than just muscles and joints. New research suggests ultramarathons can alter red ...

Fran Drescher opens up about her uterine cancer battle, reflecting on how unresolved emotional trauma may have contributed to ...